Published in Head Neck on December 01, 2003
The molecular immunology of mucositis: implications for evidence-based research in alternative and complementary palliative treatments. Evid Based Complement Alternat Med (2005) 1.09
Prevention of radiation-induced oral mucositis after adenoviral vector-mediated transfer of the keratinocyte growth factor cDNA to mouse submandibular glands. Clin Cancer Res (2009) 1.07
Anti-inflammatory cytokines: important immunoregulatory factors contributing to chemotherapy-induced gastrointestinal mucositis. Chemother Res Pract (2012) 0.95
Cytokines levels, severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer--a prospective pilot study. Radiat Oncol (2010) 0.90
Effect of low-level laser therapy on inflammatory mediator release during chemotherapy-induced oral mucositis: a randomized preliminary study. Lasers Med Sci (2014) 0.82
Review of preclinical studies on treatment of mucositis and associated pain. J Dent Res (2014) 0.81
The role of Smad7 in oral mucositis. Protein Cell (2015) 0.80
Healing action of topical chamomile on 5-fluoracil induced oral mucositis in hamster. Support Care Cancer (2010) 0.80
Oral Mucositis: understanding the pathology and management. Hippokratia (2012) 0.79
A survey of chinese medicinal herbal treatment for chemotherapy-induced oral mucositis. Evid Based Complement Alternat Med (2013) 0.78
Chemo-radiotherapy induced oral mucositis during IMRT for head and neck cancer - An assessment. Med Oral Patol Oral Cir Bucal (2015) 0.77
Azilsartan reduced TNF-α and IL-1β levels, increased IL-10 levels and upregulated VEGF, FGF, KGF, and TGF-α in an oral mucositis model. PLoS One (2015) 0.77
Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics. Pharmacol Res (2016) 0.76
Prevention and management of antineoplastic therapy induced oral mucositis. Natl J Maxillofac Surg (2010) 0.76
Photobiomodulation reduces oral mucositis by modulating NF-kB. J Biomed Opt (2015) 0.76
Effect of Hippophae rhamnoides Extract on Oxidative Oropharyngeal Mucosal Damage Induced in Rats Using Methotrexate. Clin Exp Otorhinolaryngol (2016) 0.75
Mouth-rinses for the prevention of chemotherapy induced oral mucositis in children: a systematic review. Iran J Ped Hematol Oncol (2015) 0.75
Effect of dietary boron on 5-fluorouracil induced oral mucositis in rats. Eur J Dent (2013) 0.75
Biomarkers in the assessment of oral mucositis in head and neck cancer patients: a systematic review and meta-analysis. Support Care Cancer (2017) 0.75
Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc (2005) 4.02
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc (2010) 3.44
Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer (2004) 2.29
Common benign oral soft tissue masses. Dent Clin North Am (2005) 2.00
Defining and diagnosing burning mouth syndrome: Perceptions of directors of North American postgraduate oral medicine and orofacial pain programs. J Am Dent Assoc (2013) 1.98
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer (2014) 1.93
Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant (2004) 1.91
Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis. Support Care Cancer (2006) 1.64
Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer (2006) 1.61
Clinical presentation and management of mTOR inhibitor-associated stomatitis. Oral Oncol (2011) 1.54
Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens. Biol Blood Marrow Transplant (2005) 1.44
Nonsteroidal anti-inflammatory drugs: confusion, controversy and dental implications. J Can Dent Assoc (2005) 1.24
How should we measure and report radiotherapy-induced xerostomia? Semin Radiat Oncol (2003) 1.23
Burning mouth syndrome. Adv Otorhinolaryngol (2006) 1.18
A review of oral toxicity associated with mTOR inhibitor therapy in cancer patients. Oral Oncol (2013) 1.10
The Impact of a Science Education Game on Students' Learning and Perception of Inhalants as Body Pollutants. J Sci Educ Technol (2012) 1.07
Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis. Head Neck (2004) 1.06
Oral manifestations of habitual khat chewing: a case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 1.05
Mucositis: biology and management. Curr Opin Otolaryngol Head Neck Surg (2007) 1.04
Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer (2006) 1.02
In vivo imaging of oral mucositis in an animal model using optical coherence tomography and optical Doppler tomography. Clin Cancer Res (2007) 1.02
Methamphetamine and its impact on dental care. J Can Dent Assoc (2005) 0.99
AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis. Oral Oncol (2010) 0.98
Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma. J Support Oncol (2007) 0.96
Pilot study: Raman spectroscopy in differentiating premalignant and malignant oral lesions from normal mucosa and benign lesions in humans. Head Neck (2014) 0.96
Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy. Cancer (2008) 0.92
Palifermin for management of treatment-induced oral mucositis in cancer patients. Biologics (2009) 0.91
Topical review-connective tissue diseases: orofacial manifestations including pain. J Orofac Pain (2007) 0.88
Topical minocycline and tetracycline rinses in treatment of recurrent aphthous stomatitis: a randomized cross-over study. Dermatol Online J (2007) 0.87
Oral and serum IL-6 levels in oral lichen planus patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2004) 0.86
New thoughts on the pathobiology of regimen-related mucosal injury. Support Care Cancer (2006) 0.83
Topical minocycline for managing symptoms of recurrent aphthous stomatitis. Spec Care Dentist (2008) 0.82
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. Tex Dent J (2012) 0.82
Links between regimen-related toxicities in patients being treated for colorectal cancer. Curr Opin Support Palliat Care (2009) 0.81
The prevention and treatment of radiotherapy - induced xerostomia. Semin Radiat Oncol (2003) 0.81
Feeding tube use in patients with head and neck cancer. Head Neck (2014) 0.81
Parameters defining the potential applicability of Raman spectroscopy as a diagnostic tool for oral disease. J Biomed Opt (2009) 0.80
Review of current treatment practices for carcinoma of the head and neck. Expert Opin Pharmacother (2005) 0.79
Inflammation and genetic risk indicators for early periodontitis in adults. J Periodontol (2010) 0.78
Oral ulcers in patients with advanced breast cancer receiving everolimus: a case series report on clinical presentation and management. Oral Surg Oral Med Oral Pathol Oral Radiol (2013) 0.78
Breaking bad medical news in a dental care setting. J Am Dent Assoc (2013) 0.78
TNF and oral mucositis: response to effect of selective inhibitors of inflammation on oral mucositis: preclinical studies. Radiother Oncol 2009; 92:472-6. Radiother Oncol (2010) 0.77
Emerging therapies for the prevention and treatment of oral mucositis. Expert Opin Emerg Drugs (2014) 0.76
Oral health in cancer therapy. Tex Dent J (2009) 0.76
A prospective study to assess in vivo optical coherence tomography imaging for early detection of chemotherapy-induced oral mucositis. Lasers Surg Med (2013) 0.75
Toward multimodality oral cancer diagnosis in the XXI century: Blending cutting edge imaging and genomic/proteomic definition of suspicious lesions. Bioinformation (2011) 0.75
Authors' response. J Am Dent Assoc (2014) 0.75
A Systematic Review of the Symptom Distress Scale in Advanced Cancer Studies. Cancer Nurs (2016) 0.75
The Sandwich Generation Diner: Development of a Web-Based Health Intervention for Intergenerational Caregivers. JMIR Res Protoc (2016) 0.75
Oral health in cancer therapy. Todays FDA (2009) 0.75
Diet and prevention of oral cancer: strategies for clinical practice. J Am Dent Assoc (2011) 0.75
The correlation between prevalence of oral manifestations of HIV and CD4+ lymphocyte counts weakens with time. J Acquir Immune Defic Syndr (2006) 0.75
A pilot study evaluating the safety and microbiologic efficacy of an economically viable antimicrobial lozenge in patients with head and neck cancer receiving radiation therapy. Head Neck (2002) 0.75